Owkin Dx Overview

  • Year Founded
  • 2026

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $33.1M

  • Investors
  • 6

Owkin Dx General Information

Description

Developer of AI-based diagnostic tests designed to support precision oncology and biomarker-driven medicine. The company applies machine learning and foundation models to histopathology and multimodal clinical data, offering AI-enabled biomarker discovery, risk and outcome prediction, treatment-response assessment, and workflow integration with pathology and oncology systems, enabling healthcare providers and biopharmaceutical companies to conduct scalable, data-driven testing that supports targeted therapies, clinical decision-making, and streamlined diagnostic pathways across oncology.

Contact Information

Website
waiv.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 63 Rue Sainte-Anne
  • 75002 Paris
  • France
Primary Industry
Decision/Risk Analysis
Other Industries
Biotechnology
Laboratory Services (Healthcare)
Vertical(s)
Big Data, Artificial Intelligence & Machine Learning, Life Sciences, Oncology
Corporate Office
  • 63 Rue Sainte-Anne
  • 75002 Paris
  • France

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Owkin Dx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 02-Mar-2026 $33.1M Completed Generating Revenue
1. Spin-Off 01-Jan-2026 Completed Generating Revenue
To view Owkin Dx’s complete valuation and funding history, request access »

Owkin Dx Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
AIC Venture Capital Minority
Cross Road Biotech Venture Capital Minority
Karista (Paris) Venture Capital Minority
OTB Ventures Venture Capital Minority
Serena Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial

Owkin Dx FAQs

  • When was Owkin Dx founded?

    Owkin Dx was founded in 2026.

  • Where is Owkin Dx headquartered?

    Owkin Dx is headquartered in Paris, France.

  • What industry is Owkin Dx in?

    Owkin Dx’s primary industry is Decision/Risk Analysis.

  • Is Owkin Dx a private or public company?

    Owkin Dx is a Private company.

  • What is the current valuation of Owkin Dx?

    The current valuation of Owkin Dx is .

  • What is Owkin Dx’s current revenue?

    The current revenue for Owkin Dx is .

  • How much funding has Owkin Dx raised over time?

    Owkin Dx has raised $33.1M.

  • Who are Owkin Dx’s investors?

    AIC, Cross Road Biotech, Karista (Paris), OTB Ventures, and Serena are 5 of 6 investors who have invested in Owkin Dx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process